AtaiBeckley completed its Merger with Eli Lilly, converting each eligible common share into $6.75 in cash plus one contingent value right worth up to $2.50. Investors now hold merger consideration rather than the former common stock, while the CVRs remain tied to specified clinical and regulatory milestones and carry no voting or Dividend rights.

Key Highlights

  • AtaiBeckley’s outstanding common shares were converted into cash consideration and contingent value rights at the merger’s effective time.
  • Options priced below $6.75 received cash based on the spread and one CVR per underlying share, while higher-priced Options were cancelled without consideration.
  • Nasdaq was notified of the merger, with trading suspension and delisting requested for the former common stock.

AtaiBeckley Inc. (NASDAQ: ATAI) completed its merger with Eli Lilly and Company (NYSE: LLY) on September 11, 2026, becoming a Wholly Owned Subsidiary of Lilly. Each eligible common share converted into $6.75 in cash plus one contingent value right that can pay up to $2.50 per share.

$6.75 Cash Consideration and CVR Terms

The CVR payments depend on specified clinical and regulatory milestones involving VLS-01 and BPL-003. The CVRs are generally nontransferable, unlisted and carry no voting or dividend rights.

Ownership, Management and Listing Changes

Options with exercise prices below the $6.75 closing amount were cancelled in exchange for cash reflecting the difference between the closing amount and their exercise prices, plus one CVR per underlying share. Options priced at or above $6.75 were cancelled without consideration, while eligible restricted stock units received cash based on the closing amount and one CVR per underlying share. The former board and executive officers resigned at closing, with Christopher Anderson and Jonathan R. Haug becoming directors and Merger Sub’s officers taking corresponding company positions. Nasdaq was asked to suspend trading and begin delisting and deregistration procedures for the common stock, while Gerd Kochendoerfer received approval for a $194,000 retention Bonus subject to continued employment through closing.